Role of kappa II-A2 light chain CDR-3 junctional residues in human antibody binding to the Haemophilus influenzae type b polysaccharide - PubMed (original) (raw)

. 1998 Oct 1;161(7):3776-80.

Affiliations

PMID: 9759904

Role of kappa II-A2 light chain CDR-3 junctional residues in human antibody binding to the Haemophilus influenzae type b polysaccharide

A H Lucas et al. J Immunol. 1998.

Abstract

Abs using the kappaII-A2 V gene segment predominate the human Ab repertoire to the Haemophilus influenzae b (Hib) polysaccharide (PS). All A2 anti-Hib PS Abs sequenced to date possess a 10-amino acid L chain complementarity-determining region-3 (CDR-3) having an insertional arginine (Arg) at position 95a, the V-J junction. These findings suggest an essential requirement for this conserved Arg residue in determining Hib PS-binding affinity. We examined this requirement by performing chain recombination experiments in which a series of A2 L chains, differing at position 95a, were combined individually with an Fd region known to generate a Hib PS-combining site when paired with an A2-Arg(95a)-Jkappa1 V region. Hib PS binding of the recombinant Fabs was evaluated quantitatively using a radioantigen-binding assay. Fabs having A2 L chains with either Arg or lysine in position 95a in combination with Jkappa1 gave equivalent and strongest binding to Hib PS. Fabs having A2-Jkappa1 L chains with either tyrosine, glycine, alanine, leucine, serine, or threonine in position 95a, or having an A2-Arg(95a)-Jkappa3 L chain, gave intermediate binding. Fabs having A2-Jkappa1 L chains with glutamate or aspartate at 95a or with no junctional residue showed little or no Hib PS binding. These results demonstrate the importance of L chain junctional residue, as well as Jkappa usage and CDR-3 length, in determining Hib PS-binding affinity. Contrary to expectation, an Arg junctional residue is not essential for generating either high or intermediate affinity-binding sites.

PubMed Disclaimer

Cited by

Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.
Ghiotto F, Fais F, Valetto A, Albesiano E, Hashimoto S, Dono M, Ikematsu H, Allen SL, Kolitz J, Rai KR, Nardini M, Tramontano A, Ferrarini M, Chiorazzi N. Ghiotto F, et al. J Clin Invest. 2004 Apr;113(7):1008-16. doi: 10.1172/JCI19399. J Clin Invest. 2004. PMID: 15057307 Free PMC article.
Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable light chain repertoire.
Smithson SL, Kolibab K, Shriner AK, Srivastava N, Khuder S, Westerink MA. Smithson SL, et al. Infect Immun. 2005 Nov;73(11):7477-84. doi: 10.1128/IAI.73.11.7477-7484.2005. Infect Immun. 2005. PMID: 16239549 Free PMC article. Clinical Trial.
Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations.
Adderson EE. Adderson EE. Springer Semin Immunopathol. 2001 Dec;23(4):387-403. doi: 10.1007/s281-001-8166-x. Springer Semin Immunopathol. 2001. PMID: 11826616 Review.
Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus.
Thomson CA, Bryson S, McLean GR, Creagh AL, Pai EF, Schrader JW. Thomson CA, et al. EMBO J. 2008 Oct 8;27(19):2592-602. doi: 10.1038/emboj.2008.179. Epub 2008 Sep 4. EMBO J. 2008. PMID: 18772881 Free PMC article.

Role of kappa II-A2 light chain CDR-3 junctional residues in human antibody binding to the Haemophilus influenzae type b polysaccharide - PubMed (original) (raw)